{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T20:47:00Z","timestamp":1649191620964},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.2515\/therapie:2006066","type":"journal-article","created":{"date-parts":[[2007,3,19]],"date-time":"2007-03-19T09:23:52Z","timestamp":1174296232000},"page":"401-405","source":"Crossref","is-referenced-by-count":0,"title":["Antithrombotiques et infarctus c\u00e9r\u00e9bral : essais cliniques et besoins m\u00e9dicaux"],"prefix":"10.1016","volume":"61","author":[{"given":"Philippa","family":"Lavall\u00e9e","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.2515\/therapie:2006066_bb0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000047763","article-title":"Socioeconomic aspects of postacute care for patients with brain infarction in France","volume":"13","author":"Spieler","year":"2002","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"10.2515\/therapie:2006066_bb0015","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians\u2019 Health Study. Steering Committee of the Physicians\u2019 Health Study Research Group","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie:2006066_bb0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.2515\/therapie:2006066_bb0025","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.2515\/therapie:2006066_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"on behalf of the MATCH investigators. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomized, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.2515\/therapie:2006066_bb0035","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection","volume":"111","author":"Markus","year":"2005","journal-title":"Circulation"},{"key":"10.2515\/therapie:2006066_bb0040","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"The clopidogrel in unstable angina to prevent recurrent events trial investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"issue":"7","key":"10.2515\/therapie:2006066_bb0045","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0735-1097(03)00048-2","article-title":"Improved endothelial function by the thromboxane A2 receptor antagonist S 18 886 in patients with coronary artery disease treated with aspirin","volume":"41","author":"Belhassen","year":"2003","journal-title":"JACC"},{"key":"10.2515\/therapie:2006066_bb0050","first-page":"P603","article-title":"The TP receptor antagonist S 18 886 improves endothelial dysfunction on a long-term basis in atheroclerotic patients","volume":"25","author":"Belhassen","year":"2004","journal-title":"Eur Heart J"},{"key":"10.2515\/therapie:2006066_bb0055","doi-asserted-by":"crossref","first-page":"7886","DOI":"10.1002\/ana.410320113","article-title":"Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke","volume":"32","author":"Del Zoppo","year":"1992","journal-title":"Ann Neurol"},{"issue":"5 Suppl 2","key":"10.2515\/therapie:2006066_bb0060","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1212\/WNL.57.suppl_2.S69","article-title":"Overview of Cochrane thrombolysis meta-analysis","volume":"57","author":"Wardlaw","year":"2001","journal-title":"Neurology"},{"key":"10.2515\/therapie:2006066_bb0065","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/384123b0","article-title":"Neuronal cell death and tPA","volume":"384","author":"Tsirka","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.2515\/therapie:2006066_bb0070","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1161\/01.STR.0000149938.08731.2c","article-title":"The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase","volume":"36","author":"Hacke","year":"2005","journal-title":"Stroke"},{"key":"10.2515\/therapie:2006066_bb0075","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.STR.0000157668.39374.56","article-title":"Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators. Emergency administration of Abciximab for treatment of patients with acute ischemic stroke","volume":"36","year":"2005","journal-title":"Stroke"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716304152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716304152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T07:01:39Z","timestamp":1554274899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716304152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0040595716304152"],"URL":"https:\/\/doi.org\/10.2515\/therapie:2006066","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}